Decision for hysterectomy as a modifiable cardiovascular risk factor: A systematic review and meta-analysis

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective

To describe the role of hysterectomy in modifying the major atherosclerotic cardiovascular disease risk factors.

Data sources

PubMed, Cochrane Library, Embase, and ScienceDirect were searched from database inception to March 10, 2026.

Study eligibility criteria

Full-text randomized controlled trials, case-control studies, cross-sectional studies, cohort studies, case series, and experimental studies reporting new-onset cardiovascular events, diabetes mellitus, hypertension, dyslipidemia, or other metabolic effects following hysterectomy were eligible. Reviews and book chapters were excluded.

Study appraisal and synthesis methods

Study selection and data extraction were performed independently by multiple reviewers with conflicts resolved by consensus. Cohort study quality was assessed with the Newcastle-Ottawa Scale; a modified version assessed cross-sectional studies. Meta-analyses were performed using a generic inverse-variance random-effects model for each outcome, stratified by study design (cross-sectional versus cohort) and effect measure (adjusted odds ratio, adjusted hazard ratio, or relative risk). Narrative synthesis was performed for outcomes not meeting criteria for meta-analysis.

Results

Twenty studies (11 cohort, 8 cross-sectional, 1 mixed design) were included after screening 18,337 records from four databases. Hysterectomy was associated with significantly increased risk of hypertension (cross-sectional odds ratio 1.32, 95% confidence interval 1.18– 1.48; cohort hazard ratio 1.19, 95% confidence interval 1.09–1.30), diabetes (cross-sectional odds ratio 1.21, 95% confidence interval 1.11–1.32; cohort hazard ratio 1.20, 95% confidence interval 1.13–1.29), hyperlipidemia (hazard ratio 1.21, 95% confidence interval 1.13–1.29), obesity (odds ratio 1.24, 95% confidence interval 1.03–1.50), and metabolic syndrome (odds ratio 1.24, 95% confidence interval 1.08–1.44).

Conclusions

Hysterectomy is associated with increased risk of hypertension, diabetes, hyperlipidemia, obesity, and metabolic syndrome, key modifiable atherosclerotic cardiovascular disease risk factors. Active cardiovascular risk assessment and follow-up may be warranted for women who undergo hysterectomy, particularly at a young age.

Article activity feed